{"id":"CHEMBL1014","canonicalSmiles":"CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1","inchiKey":"GHOSNRCGJFBJIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANDESARTAN CILEXETIL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amias","Atacand","Candesartan cilexetil","Ratacand"],"synonyms":["Candesartan","Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester","Candesartan cilexetil","NSC-758697","TCV-116"],"crossReferences":{"DailyMed":["candesartan%20cilexetil"],"PubChem":["144212519","26748952"],"drugbank":["DB00796"],"chEBI":["3348"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["HP_0003124","HP_0000093","EFO_0001645","EFO_0000401","MONDO_0007254","EFO_0000373","EFO_0000319","EFO_1001496","EFO_0003843","EFO_0000537","EFO_0003913","EFO_1001153","EFO_0003914","EFO_1001150","MONDO_0001134","MONDO_0100096","MONDO_0021187","EFO_0003144","MONDO_0005147","EFO_0000712","EFO_0000612","MONDO_0005148","EFO_0000400","HP_0001653"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 8 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL103043","canonicalSmiles":"N=C(N)c1ccc2cccc(Nc3ncccn3)c2c1","inchiKey":"GRQLDCHTDNYVQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL103043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04059"],"chEBI":["46311"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL104166","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3ccc(CN)cc3)cc(Nc3ncccn3)c2c1","inchiKey":"CSWQJKHBMACTGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL104166","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108541","canonicalSmiles":"O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1","inchiKey":"OXNIZHLAWKMVMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRINITROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Picric acid","Trinitrophenol"],"crossReferences":{"Wikipedia":["Picric_acid"],"drugbank":["DB03651"],"chEBI":["46149"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1089318","canonicalSmiles":"Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1","inchiKey":"ASOADIZOVZTJSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPICAPONE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ongentys"],"synonyms":["BIA 9-1067","BIA-9-1067","BIA-91067","Ongentys","Opicapone"],"crossReferences":{"DailyMed":["opicapone"],"drugbank":["DB11632"]},"linkedTargets":{"rows":["ENSG00000093010"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for parkinson disease."}
{"id":"CHEMBL1093059","canonicalSmiles":"CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1","inchiKey":"TXGZJQLMVSIZEI-UQMAOPSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARDOXOLONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Cyano-3,12-Dioxooleana-1,9(11)-Dien-28-Oic Acid","Bardoxolone","CDDO","RTA 401","RTA-401"],"crossReferences":{"PubChem":["531235"],"drugbank":["DB12651"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1123","canonicalSmiles":"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1","inchiKey":"CURUTKGFNZGFSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICYCLOMINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bentyl","Dicyclomine","Dicycloverine","Dicymine","Kolantyl"],"crossReferences":{"DailyMed":["dicyclomine%20hydrochloride"],"PubChem":["11111098","11112188","144207120","170464896","50100226","50104289","90341021"],"Wikipedia":["Dicycloverine"],"drugbank":["DB00804"],"chEBI":["4514"]},"childChemblIds":["CHEMBL1200479"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282","EFO_0000555"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for gastrointestinal disease and irritable bowel syndrome."}
{"id":"CHEMBL11298","canonicalSmiles":"N[C@@H](CO)C(=O)O","inchiKey":"MTCFGRXMJLQNBG-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-serine","NSC-118365","Serine"],"crossReferences":{"PubChem":["11111802","11113417","11113418"],"Wikipedia":["Serine"],"drugbank":["DB00133"],"chEBI":["17115"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1139","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\\CCCC(=O)O)C[C@@H]21","inchiKey":"KAQKFAOMNZTLHT-OZUDYXHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPOPROSTENOL","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ACT-385781A","Epoprostenol","Flolan","PG-I2","Pgi2","Pgx","Prostacyclin","Prostaglandin i2","Prostaglandin x","U-53,217","U-53217"],"crossReferences":{"DailyMed":["epoprostenol%20sodium"],"PubChem":["26754811","50112680"],"drugbank":["DB01240"],"chEBI":["15552"]},"childChemblIds":["CHEMBL962"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0003086","MONDO_0005149","EFO_0001361","EFO_0000713","MONDO_0100096","EFO_0002687","EFO_0003144","EFO_0003827","EFO_0000319","HP_0004419","MONDO_0043510","MONDO_0005148"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for pulmonary arterial hypertension and recurrent thrombophlebitis and has 7 investigational indications."}
{"id":"CHEMBL116943","canonicalSmiles":"C1CCc2nnnn2CC1","inchiKey":"CWRVKFFCRWGWCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTYLENETETRAZOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cardiazol"],"synonyms":["Cardiozol","Cenazol","Coranormol","Corazole","Coryvet","Korazol","Korazole","Leptazol","Leptazole","Metrazol","Metrazole","NSC-5729","NSC-66489","Pentamethylenetetrazol","Pentamethylenetetrazole","Pentetrazol","Pentylenetetrazol","Pentylenetetrazole"],"crossReferences":{"PubChem":["11111647","11111648","124881152","26747621","50106807","90341004"],"Wikipedia":["Pentylenetetrazol"],"drugbank":["DB13415"],"chEBI":["34910"]},"childChemblIds":["CHEMBL350551"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1187833","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2","inchiKey":"FVTWTVQXNAJTQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMECLIDINIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GSK-573719","GSK573719","Umeclidinium","Umeclidinium cation","Umeclidinium ion"],"crossReferences":{"DailyMed":["umeclidinium%20bromide"],"drugbank":["DB09076"]},"childChemblIds":["CHEMBL523299"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000464","EFO_0006505","MONDO_0004979","HP_0000975","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL1189150","canonicalSmiles":"N=c1c[n+](N2CCOCC2)[n-]o1","inchiKey":"FKDHHVKWGRFRTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINSIDOMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Linsidomine"],"crossReferences":{"PubChem":["11111414","90340687"],"drugbank":["DB13400"]},"childChemblIds":["CHEMBL538104"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200402","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=S(=O)(O)c1ccccc1","inchiKey":"ZPBWCRDSRKPIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMLODIPINE BESYLATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1491","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amlodipine besylate","Norvasc"],"synonyms":["Amlodipine (as besilate)","Amlodipine benzenesulfonate","Amlodipine besilate","Amlodipine besylate","Amlor","Antacal","Lodipressin","Monopina","NSC-758922","UK-48,340-26","UK-48340-26"],"crossReferences":{"DailyMed":["amlodipine%20besylate"],"PubChem":["144205078","144207025","26749852"],"chEBI":["2669"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["HP_0003124","HP_0000093","EFO_0001645","EFO_1000013","EFO_0000373","EFO_0004911","EFO_0000537","EFO_0003913","MONDO_0001134","Orphanet_79292","MONDO_0021187","EFO_0000712","EFO_0000612","EFO_0000668"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 10 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200789","canonicalSmiles":"O=P([O-])(O)OCC(Cl)(Cl)Cl.[Na+]","inchiKey":"WFKJEZKHPGDCRK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOFOS SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201317","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triclos"],"synonyms":["SCH 10159","SCH-10159","Trichloroethyl phosphate sodium","Triclofos monosodium salt","Triclofos sodium","Tricloryl"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201014","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"VJZLQIPZNBPASX-OJJGEMKLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE SODIUM PHOSPHATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201231","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Codelsol","Cortisate","Hydeltrasol","Inflamase","Inflamase forte","Inflamase mild","Metreton","Orapred","Orapred odt","Pediapred","Predair","Predair forte","Prednisolone sodium phosphate","Predsol","Predsol-n"],"synonyms":["NSC-759187","Prednisolone 21-disodium phosphate","Prednisolone sodium phosphate","Prednisoloni natrii phosphas"],"crossReferences":{"DailyMed":["prednisolone%20sodium%20phosphate"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000559","EFO_0000768","EFO_0003929","EFO_0009448","EFO_0000565","MP_0001845","EFO_1001231","MONDO_0005301","MONDO_0002280","EFO_0007126","EFO_0004255","EFO_1001226","MONDO_0004979","EFO_0000341","EFO_0007141","EFO_0007415"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 13 approved and 3 investigational indications."}
{"id":"CHEMBL1201063","canonicalSmiles":"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl","inchiKey":"XWIHRGFIPXWGEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPAFENONE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL631","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arythmol","Propafenone hydrochloride","Rythmol","Rythmol sr","Rytmonorm"],"synonyms":["NSC-758640","Propafenone hcl","Propafenone hydrochloride"],"crossReferences":{"DailyMed":["propafenone%20hydrochloride"],"PubChem":["26747617","26747618","50106779","50106780","50106781","56422489","855997"],"chEBI":["8466"]},"linkedTargets":{"rows":["ENSG00000168356","ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169252","ENSG00000169432","ENSG00000043591","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":12},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144","HP_0004308"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for atrial fibrillation and ventricular arrhythmia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201161","canonicalSmiles":"CC(=O)O.NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"UILOTUUZKGTYFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFENIDE ACETATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL419","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mafenide acetate","Sulfamylon"],"synonyms":["Mafenide acetate"],"crossReferences":{"DailyMed":["mafenide%20acetate"],"PubChem":["855706"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for burn and bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1201380","name":"CHEMBL1201380","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00223"]}}
{"id":"CHEMBL1201631","drugType":"Protein","blackBoxWarning":true,"name":"INSULIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrezza","Exubera","Humulin","Humulin br","Humulin r","Humulin r kwikpen","Humulin r pen","Ins humulin r","Insuman infusat","Myxredlin","Novolin","Novolin r","Velosulin","Velosulin br","Velosulin br human"],"synonyms":["INSULIN BOVINE INSULIN","Insulin","Insulin (human)","Insulin Recombinant Human","Insulin bovine","Insulin human","Insulin human (biosynthesis)","Insulin human (synthesis)","Insulin human semisynthetic","Insulin recombinant human","Insulin recombinant purified human"],"crossReferences":{"DailyMed":["insulin%20human","insulin%20recombinant%20human"],"DrugCentral":["5003"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003095","EFO_0000401","EFO_0003768","EFO_1001951","EFO_0003914","EFO_1000653","HP_0100543","EFO_0004593","EFO_0003884","EFO_0000400","HP_0000842","HP_0003124","EFO_1000906","HP_0001919","EFO_0009516","EFO_1001050","HP_0100806","EFO_0003840","MONDO_0100096","EFO_0007430","MONDO_0021187","HP_0003074","HP_0001943","EFO_0000341","EFO_0000516","EFO_0005672","MONDO_0005090","EFO_0006834","HP_0002153","EFO_0000373","EFO_0009267","MONDO_0018555","EFO_1000783","MONDO_0002146","EFO_0000289","MONDO_0005180","EFO_0003144","EFO_0000712","EFO_0004143","EFO_0003917","HP_0002140","EFO_0001645","HP_0011015","EFO_0003929","EFO_0001358","EFO_0001073","EFO_0003843","EFO_0000537","EFO_1000985","EFO_0002614","MONDO_0005147","EFO_0008583","EFO_0000612","MONDO_0005148","EFO_0005411","EFO_0009492"],"count":57},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 47 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201658","drugType":"Small molecule","blackBoxWarning":false,"name":"ALKAVERVIR","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Veriloid"],"synonyms":["Alkavervir"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1230604","canonicalSmiles":"COc1ccc(-c2c(S(C)(=O)=O)ccc(C(=O)c3cnn(C(C)(C)C)c3O)c2C)cc1","inchiKey":"AVFXBZIGDFPGBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02850"],"chEBI":["40290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231557","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1ccc(C#N)cc1)C2=O","inchiKey":"MVYDBJXCIFMINH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232131","canonicalSmiles":"O=S(=O)(O)c1cc(O)ccc1O","inchiKey":"IKQCSJBQLWJEPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOBESILIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dobesilate"],"crossReferences":{"drugbank":["DB13529"],"chEBI":["71157"]},"childChemblIds":["CHEMBL4740527","CHEMBL2106191","CHEMBL1707052","CHEMBL1514715"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and varicose veins and has 5 investigational indications."}
{"id":"CHEMBL1233001","canonicalSmiles":"C[C@H]1O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LQEBEXMHBLQMDB-GDJBGNAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02547"],"chEBI":["17661"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235351","canonicalSmiles":"O=C(O)CCCCCC(=O)O","inchiKey":"WLJVNTCWHIRURA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMELIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pimelic acid"],"crossReferences":{"PubChem":["144208369"],"drugbank":["DB01856"],"chEBI":["30531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235353","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(CN)c1O","inchiKey":"ZMJGSOSNSPKHNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAMINE PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206246","50125780"],"drugbank":["DB02142"],"chEBI":["18335"]},"childChemblIds":["CHEMBL3989779"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236345","canonicalSmiles":"Cc1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"SPSSULHKWOKEEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRINITROTOLUENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4,6-Trinitrotoluene"],"crossReferences":{"Wikipedia":["Trinitrotoluene"],"drugbank":["DB01676"],"chEBI":["46053"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276310","canonicalSmiles":"CO[C@@]1(NC(=O)C(C(=O)O)c2ccsc2)C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@@H]21","inchiKey":"BVCKFLJARNKCSS-DWPRYXJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOCILLIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL 17421 FREE ACID","BRL 17421 [AS SODIUM]","BRL-17421","BRL-17421 FREE ACID","Temocillin"],"crossReferences":{"drugbank":["DB12343"],"chEBI":["51817"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1314","canonicalSmiles":"CC(S)C(=O)NCC(=O)O","inchiKey":"YTGJWQPHMWSCST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOPRONIN","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acadione","Captimer","Thiola","Thiola ec","Tiopronin"],"synonyms":["NSC-760416","Tiopronin"],"crossReferences":{"DailyMed":["tiopronin"],"PubChem":["144205207","170465217","29215361"],"TG-GATEs":["104"],"Wikipedia":["Tiopronin"],"drugbank":["DB06823"],"chEBI":["32229"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 3 investigational indications."}
{"id":"CHEMBL1398126","canonicalSmiles":"Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N.O.O","inchiKey":"LTKVFMLMEYCWMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMILORIDE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL945","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amilamont","Amiloride hydrochloride","Amilospare 5","Amoride","Berkamil","Midamor"],"synonyms":["Amiloride hcl","Amiloride hydrochloride","Amiloride hydrochloride dihydrate","Amiloridi hydrochloridum","Amipramidine","NSC-755847"],"crossReferences":{"DailyMed":["amiloride%20hydrochloride"],"PubChem":["11113002"],"chEBI":["2640"]},"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["EFO_0004269","Orphanet_586","EFO_0000373","EFO_1001496","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL139835","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"UWFYSQMTEOIJJG-FDTZYFLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROTERONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Androcur","Androcur 10","Cyprostat","Diane"],"synonyms":["Cyproterone","Cyproterone acetate","NSC-81430","SH 714","SH-714"],"crossReferences":{"PubChem":["144204615","144208884","144213258","170465682","17389953","26752883","46500455","49737417","90340797"],"drugbank":["DB04839"],"chEBI":["50743"]},"linkedTargets":{"rows":["ENSG00000082175","ENSG00000113580","ENSG00000169083"],"count":3},"linkedDiseases":{"rows":["EFO_0001065","EFO_0000673","EFO_0000536","HP_0031217","EFO_0009867","EFO_0003894","MONDO_0008315","EFO_0000660","EFO_0003922"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1474963","canonicalSmiles":"CCc1oc2ccccc2c1C(=O)c1ccc(O)cc1","inchiKey":"RFRXIWQYSOIBDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZARONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hepatotoxicity"],"year":1992},"tradeNames":[],"synonyms":["Benzarone","L 2197","L-2197","NSC-82134"],"crossReferences":{"PubChem":["24424590"],"chEBI":["34559"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1992 due to Hepatotoxicity."}
{"id":"CHEMBL1480987","canonicalSmiles":"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1","inchiKey":"WZHCOOQXZCIUNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLANDELATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclobral","Cyclospasmol"],"synonyms":["Cyclandelate","Cyclergine","Cyclolyt","Cyclomandol","NSC-758910","Natil","Novodil","Perebral","Spasmocyclon (3m)"],"crossReferences":{"PubChem":["144205278","29215478"],"drugbank":["DB04838"],"chEBI":["3988"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1575","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"FRPJXPJMRWBBIH-RBRWEJTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRAMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estramustine","NSC-89201","RO 22-2296/000","RO-22-2296000","RO-222296000"],"crossReferences":{"PubChem":["144205760","170466403","26758003","396503"],"Wikipedia":["Estramustine"],"drugbank":["DB01196"],"chEBI":["4868"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1594","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O","inchiKey":"GHOKWGTUZJEAQD-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOTHENIC ACID","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calc pantoth","Cantopal","Pantothenic Acid","Vitamin B 5"],"synonyms":["Chick antidermatitis factor","Pantothenate","Pantothenic acid","Pantothenic acid ","Pantothenic acid (d)","Vitamin b-5","Vitamin b5"],"crossReferences":{"Wikipedia":["Pantothenic_acid"],"drugbank":["DB01783"],"chEBI":["46905"]},"childChemblIds":["CHEMBL1901349"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for chronic kidney disease and has 2 investigational indications."}
{"id":"CHEMBL1619758","canonicalSmiles":"CCC(N)Cc1c[nH]c2ccccc12","inchiKey":"ZXUMUPVQYAFTLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.et","Etryptamine","Monase","NSC-88061","RO 3-1932"],"crossReferences":{"PubChem":["104171412","144206171"],"drugbank":["DB01546"]},"childChemblIds":["CHEMBL1412355"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628504","canonicalSmiles":"Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1.Cl","inchiKey":"KZVVGZKAVZUACK-BJILWQEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILPIVIRINE HYDROCHLORIDE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL175691","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edurant"],"synonyms":["Rilpivirine (as hydrochloride)","Rilpivirine hcl","Rilpivirine hydrochloride","TMC278 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["rilpivirine%20hydrochloride"],"chEBI":["68602"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for hiv infection."}
{"id":"CHEMBL1684950","canonicalSmiles":"CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1","inchiKey":"IQIKXZMPPBEWAD-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUVECALTAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-8998","Cx-8998","JZP-385","JZP385","MK-8998","Mk-8998","Suvecaltamide"],"childChemblIds":["CHEMBL4802242"],"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000474","EFO_0003108"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL168634","canonicalSmiles":"Cc1ccc(S(=O)(=O)N2N=Cc3ccccc3B2O)cc1","inchiKey":"UQIDNSKBUXCODH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL168634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08265"],"chEBI":["83945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1689","canonicalSmiles":"Cl.c1ccc(CC2=NCCN2)cc1","inchiKey":"RHTNTTODYGNRSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLAZOLINE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL770","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzidazol","Priscol","Priscoline"],"synonyms":["Benzazoline hydrochloride","NSC-757353","TCMDC-125842","Tolazoline HCl","Tolazoline hcl","Tolazoline hydrochloride"],"crossReferences":{"PubChem":["144203890","14742771","170465219","26748277"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1689285","canonicalSmiles":"O=S([O-])O.[Na+]","inchiKey":"DWAQJAXMDSEUJJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BISULFITE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-222","E222","INS NO.222","INS-222","Monosodic sulphite","NSC-60680","Sodium bisulfite","Sulfurous acid, monosodium salt"],"crossReferences":{"Wikipedia":["Sodium_bisulfite"],"drugbank":["DB14015"],"chEBI":["26709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697751","canonicalSmiles":"CC(C)Nc1ncccn1.O=P(O)(O)O","inchiKey":"CXEBHWXMQKIKPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAXONINE PHOSPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1740513","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["Isaxonine phosphate","Nerfactor"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984 due to Hepatotoxicity."}
{"id":"CHEMBL1697766","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1","inchiKey":"WEYVCQFUGFRXOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perazine"],"crossReferences":{"PubChem":["144206523","29215456"],"drugbank":["DB12710"],"chEBI":["59118"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1742993","drugType":"Antibody","blackBoxWarning":false,"name":"BLOSOZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Blosozumab","LY-2541546","LY2541546"],"linkedTargets":{"rows":["ENSG00000167941"],"count":1},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003882"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743009","drugType":"Antibody","blackBoxWarning":false,"name":"EFUNGUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mycograb"],"synonyms":["Efungumab","HSP-90MAB","HSP90MAB","MYC-123","MYC-123A","MYC-123A MYC-123B MYC-124 HSP90MAB","MYC-123B","MYC-124","MYC123","MYC123A","MYC123B","MYC124"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743057","drugType":"Protein","blackBoxWarning":false,"name":"PEGSUNERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegsunercept","STNF-RI"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1755","canonicalSmiles":"Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2","inchiKey":"IKENVDNFQMCRTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONIVAPTAN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Conivaptan"],"crossReferences":{"Wikipedia":["Conivaptan"],"drugbank":["DB00872"],"chEBI":["681850"]},"childChemblIds":["CHEMBL1201108"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148"],"count":2},"linkedDiseases":{"rows":["EFO_0001422","HP_0002902","EFO_0003144","EFO_0001421","EFO_0000319","MONDO_0043510"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for heart failure and cardiovascular disease and has 5 investigational indications."}
{"id":"CHEMBL178090","canonicalSmiles":"NCc1ccc(-c2cccnc2)o1","inchiKey":"LENAVORGWBTPJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07621"],"chEBI":["41804"]},"childChemblIds":["CHEMBL4584258"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1818442","canonicalSmiles":"Cl.Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl","inchiKey":"KAGBHVBIOJBGBD-NINOIYOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITIFADINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL592374","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amitifadine hydrochloride","DOV 21947","DOV-21,947 HYDROCHLORIDE","DOV-21947","DOV-21947 HYDROCHLORIDE","EB-1010","EB-1010 HYDROCHLORIDE"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1823241","canonicalSmiles":"O=C(CCCCCCCCC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314)Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"ALOIOAGKUOQNID-ITCIXCFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINALBUPHINE SEBACATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dinalbuphine sebacate","Nalbuphine sebacate","Naldebain","Sebacoyldinalbuphine"],"crossReferences":{"drugbank":["DB15341"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL18850","canonicalSmiles":"O=C1CCCCC1","inchiKey":"JHIVVAPYMSGYDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXANONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclohexanone"],"crossReferences":{"PubChem":["144209319","144213067","17389954","56462788"],"Wikipedia":["Cyclohexanone"],"drugbank":["DB02060"],"chEBI":["17854"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1889041","canonicalSmiles":"CC(Cc1ccc(C(C)(C)C)cc1)CN1CCCCC1","inchiKey":"MGNFYQILYYYUBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPROPIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenpropidin","Patrol"],"crossReferences":{"PubChem":["29217960"],"drugbank":["DB12728"],"chEBI":["83291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1892145","canonicalSmiles":"CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32","inchiKey":"WYJAPUKIYAZSEM-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBURNINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3.alpha.,16.alpha.-eburnamonine","Eburnamonine (-)-form","NSC-322920","Vinburnine"],"crossReferences":{"PubChem":["144203611","170466205","457665","56463657"],"drugbank":["DB13793"],"chEBI":["4740"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL199237","canonicalSmiles":"O=C(NCc1ccccn1)c1ccc(Oc2ccccc2)cc1","inchiKey":"HVLSCZSVTCNAQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07459"],"chEBI":["41135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2013119","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+]","inchiKey":"VLQLUZFVFXYXQE-USRGLUTNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIGOSERTIB SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1241855","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Estybon"],"synonyms":["ON 01910 SODIUM","ON 01910.NA","ON-01910","ON-01910 SODIUM","ON-01910.NA","ON01910 SODIUM","On-01910.na","Rigosertib sodium","SYB C-1101"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2103793","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"QUWFSKKBMDKAHK-SBOJBMMISA-A","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AGATOLIMOD SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2103792","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agatolimod sodium","Agatolimod tricosasodium salt","CPG 7909","CPG-7909","PF-03512676","PF-3512676","Vaximmune"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0003869","MONDO_0019465","EFO_0007444","EFO_0000756","EFO_0000681","EFO_0002913","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_1001469","EFO_0005952","MONDO_0008315","EFO_0003060","EFO_0000311","HP_0100806","MONDO_0000544","EFO_0001068","EFO_0000095","EFO_0000096","EFO_0000764","EFO_0000191","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_1000550"],"count":26},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL2105039","canonicalSmiles":"c1ccc(CN(CCN2CCCC2)c2ccccc2)cc1","inchiKey":"MXHODDGKGSGCDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTAPYRRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Histapyrrodine"],"crossReferences":{"drugbank":["DB13479"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105712","canonicalSmiles":"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"USNRYVNRPYXCSP-JUGPPOIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFATINIB DIMALEATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1173655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilotrif"],"synonyms":["Afatinib dimaleate","Afatinib maleate","BIBW-2992 MA2","BIBW-2992-MA2","BIBW-2992MA2","BIBW2992 MA2","BIBW2992-MA2"],"crossReferences":{"DailyMed":["afatinib%20dimaleate"],"chEBI":["76003"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0001378","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for non-small cell lung carcinoma and has 1 investigational indication."}
{"id":"CHEMBL2106643","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)[O-])C(=O)OC2.[Na+]","inchiKey":"DOZYTHNHLLSNIK-JOKMOOFLSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL866","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceptava","Myfortic"],"synonyms":["ERL 080","ERL-080","Mycophenolate sodium","Mycophenolic acid sodium salt","Mycophenolic sod","NSC-116072","Sodium mycophenalate"],"crossReferences":{"chEBI":["67155"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107376","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C.Cl","inchiKey":"OOKIODJYZSVHDO-QMYFOHRPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TASIDOTIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111109","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ILX-651","ILX651","Tasidotin hydrochloride"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108628","drugType":"Small molecule","blackBoxWarning":false,"name":"PACLITAXEL POLIGLUMEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xyotax"],"synonyms":["CT-2103","L-polyglutamic paclitaxel","Opaxio","PG-TXL","Paclitaxel conjugate with poly-l-glutamic acid","Paclitaxel poliglumex"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000616","EFO_0000466","EFO_1000435","MONDO_0008170","EFO_0005842","MONDO_0007254","MONDO_0002087","EFO_0003060","EFO_0002917","EFO_1000357","EFO_0006772","MONDO_0008315","EFO_0006462","MONDO_0002158","MONDO_0008903","EFO_0000673","EFO_0000707","EFO_0003833","EFO_1000042","EFO_1000494"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2108680","drugType":"Antibody","blackBoxWarning":false,"name":"PIDILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ct-011"],"synonyms":["CT-011","Pidilizumab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","EFO_0004220","EFO_0000756","EFO_0000681","EFO_0000182","EFO_0000403","EFO_0000673","EFO_0000574","EFO_0001378"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109298","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-3617","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-3617","MEDI3617","Medi 3617","Medi-3617"],"linkedTargets":{"rows":["ENSG00000091879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002617"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109520","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN M","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN M"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109653","drugType":"Antibody","blackBoxWarning":false,"name":"BERMEKIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xilonix"],"synonyms":[" RA-18C3","Bermekimab","CA-18C3","CV-18C3","MaBp1","Ra-18c3","T2-18C3"],"linkedTargets":{"rows":["ENSG00000115008"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000365","EFO_1000710","EFO_0000676","HP_0000999","EFO_0000274","EFO_0003894","MONDO_0005148","EFO_0000717","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL220428","canonicalSmiles":"Nc1ncccc1NCc1cc(-c2ccc3cc[nH]c3c2)ccc1OCc1ccccn1","inchiKey":"KMBPJSHPAXOXBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07994"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221886","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"URWAJWIAIPFPJE-YFMIWBNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SISOMICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rickamicin","SCH 13475","Sisomicin","Sissomicin"],"crossReferences":{"drugbank":["DB12604"],"chEBI":["9169"]},"childChemblIds":["CHEMBL3989471","CHEMBL2146085"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL222649","canonicalSmiles":"CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1","inchiKey":"YUMYYTORLYHUFW-ZUDLOMHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL222649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233149","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)cc3)o2)S1","inchiKey":"BKUMVXIXUVYKDQ-GHXNOFRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233149","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49815772"],"drugbank":["DB07534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2360580","canonicalSmiles":"CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1.Cl.Cl","inchiKey":"SDBHDSZKNVDKNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLIZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bucladin","Bucladin-s","Equivert"],"synonyms":["Aphilan","Buclina","Buclizine dihydrochloride","Buclizine hcl","Buclizine hydrochloride","Buclodin","Longifene","NSC-25141","Softran","UCB 4445","UCB-4445"],"crossReferences":{"PubChem":["144203574"],"chEBI":["61193"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL249736","canonicalSmiles":"c1ccc(-c2cc(NCc3cccnc3)n3ncc(C4CC4)c3n2)cc1","inchiKey":"CCDIUVLNHCGSMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249736","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258921","canonicalSmiles":"O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21","inchiKey":"BELBBZDIHDAJOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLSULFONPHTHALEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-10459","Phenol red","Phenolsulfonphthalein","Phenolsulphonphthalein","Phenosulfophthalein"],"crossReferences":{"PubChem":["144203563","144213875","170465805","4252556","75741"],"drugbank":["DB13212"],"chEBI":["31991"]},"childChemblIds":["CHEMBL3187327"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278255","canonicalSmiles":"NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"QGPKADBNRMWEQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLINAFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clinafloxacin"],"crossReferences":{"PubChem":["26658614"],"Wikipedia":["Clinafloxacin"],"drugbank":["DB14025"]},"childChemblIds":["CHEMBL537626"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278663","canonicalSmiles":"COc1ccc(CC(C)N)cc1","inchiKey":"NEGYEDYHPHMHGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARA-METHOXYAMPHETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["beta-methoxyamphetamine","para-Methoxyamphetamine"],"crossReferences":{"PubChem":["91153"],"Wikipedia":["Para-Methoxyamphetamine"],"drugbank":["DB01472"]},"childChemblIds":["CHEMBL536709"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305666","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CN1CCN(C)CC1)OCCO3","inchiKey":"RVFGKBWWUQOIOU-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LURTOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lurtotecan"],"crossReferences":{"Wikipedia":["Lurtotecan"],"drugbank":["DB12222"]},"childChemblIds":["CHEMBL341028","CHEMBL533140","CHEMBL2447951"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3185229","canonicalSmiles":"O.O.O.O.O.O.[Cl-].[Cl-].[Mg+2]","inchiKey":"DHRRIBDTHFBPNG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnogene"],"synonyms":["Bischofite","Bischofite (mgcl2.6h2o)","E-511","INS NO.511","INS-511","Magnesia muriatica","Magnesium chloride","Magnesium chloride hexahydrate","NSC-529832","Polycatan"],"crossReferences":{"DailyMed":["magnesium%20chloride"],"PubChem":["144207444"],"chEBI":["86345"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 3 investigational indications."}
{"id":"CHEMBL3234237","canonicalSmiles":"Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F","inchiKey":"UVUYWJWYRLJHEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-37822681","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-37822681","Jnj-37822681"],"crossReferences":{"drugbank":["DB12579"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3407547","canonicalSmiles":"COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1","inchiKey":"ZZWWXIBKLBMSCS-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRSOCOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firsocostat","GS-0976","GS-ACC","Gs-0976","ND-630","Ndi-010976"],"linkedTargets":{"rows":["ENSG00000278540","ENSG00000076555"],"count":2},"linkedDiseases":{"rows":["EFO_1001249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL34124","canonicalSmiles":"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2","inchiKey":"GHBCIXGRCZIPNQ-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODANRIGAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMA-401","EMA401","Ema401","Olodanrigan","PD-126055"],"childChemblIds":["CHEMBL157510"],"linkedTargets":{"rows":["ENSG00000180772"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","MONDO_0041052"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544994","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VOLANESORSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 304801","ISIS 304801 FREE ACID","ISIS-304801","Volanesorsen","free acid"],"linkedTargets":{"rows":["ENSG00000110245"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","MONDO_0018637","Orphanet_98306"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545161","drugType":"Small molecule","blackBoxWarning":false,"name":"LY545694","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-545694","LY545694","Ly545694"],"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","HP_0030839"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545264","canonicalSmiles":"CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl","inchiKey":"GKJCVYLDJWTWQU-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2874455","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2874455","Ly-2874455"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_1001934"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545273","drugType":"Small molecule","blackBoxWarning":false,"name":"CR-3465","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr-3465"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545418","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-779788","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 788","Bms-779788","EXEL 04286652","EXEL-04286652","XL 652","XL-014","XL-652"],"linkedTargets":{"rows":["ENSG00000131408"],"count":1},"linkedDiseases":{"rows":["EFO_0003914"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3586404","canonicalSmiles":"CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1","inchiKey":"UFKLYTOEMRFKAD-SHTZXODSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONATASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATG-008","CC-223","Cc-223","Onatasertib"],"crossReferences":{"drugbank":["DB12570"]},"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001901","EFO_0000182","EFO_0000403","MONDO_0007254","EFO_0001378","EFO_0003060","EFO_0000519"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3707213","drugType":"Small molecule","blackBoxWarning":false,"name":"AUROTIOPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allochrysine","Aurotioprol","Aurotioprol sodium"],"crossReferences":{"DrugCentral":["4767"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL379845","canonicalSmiles":"COC(=O)c1cccnc1","inchiKey":"YNBADRVTZLEFNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL NICOTINATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitathone"],"synonyms":["FEMA NO. 3709","Methyl nicotinate","Methylnicotinate","NSC-13126"],"crossReferences":{"PubChem":["144205255","144212355","170465506","29215436"],"drugbank":["DB13882"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3827379","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(NCCN3CCS(=O)(=O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"XDMUFNNPLXHNKA-ZTESCHFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-955176","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-955176","Bms-955176","GSK-3532795"],"crossReferences":{"drugbank":["DB15193"]},"childChemblIds":["CHEMBL4159687"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833304","drugType":"Antibody","blackBoxWarning":false,"name":"TOSITUMOMAB 131I","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bexxar"],"synonyms":["Tositumomab (131I)","Tositumomab 131i","Tositumomab/iodine (131i) tositumomab"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0000873","MONDO_0019465","EFO_0000403","EFO_1001469","EFO_0005952","EFO_0000309","EFO_0003032","EFO_0000096","EFO_0000095","EFO_0000574","EFO_0001378","EFO_0000183","MONDO_0018906","EFO_1000550"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3916929","canonicalSmiles":"CNC(=O)C[C@H]1COc2cc(F)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2","inchiKey":"MBKYLPOPYYLTNW-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9977","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9977","AZD9977","Azd 9977","Azd-9977","Azd9977"],"crossReferences":{"drugbank":["DB15418"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003144","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3987016","canonicalSmiles":"CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1","inchiKey":"RDONXGFGWSSFMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVEBRESIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-075","ABBV075","Abbv-075","Mivebresib"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989567","canonicalSmiles":"Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"ZVIYWUUZWWBNMB-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXACILLIN SODIUM","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL819","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactocill","Cryptocillin","Oxacillin sodium","Prostaphlin"],"synonyms":["Anhydrous oxacillin sodium","Bristopen","Cryptocillin","Micropenin","NSC-527712","NSC-757253","Oxacillin sodium","Oxacillin sodium anhydrous","Oxacillin sodium monohydrate","Oxacillin sodium salt monohydrate","P-12","Penicillin p-12","Penstapho","SO 16,423","SQ 16,423","SQ-16423","Sodium oxacillin","Stapenor"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL4066936","canonicalSmiles":"COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N","inchiKey":"QZFHIXARHDBPBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VERICIGUAT","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Verquvo"],"synonyms":["BAY 1021189","BAY-1021189","MK-1242","Vericiguat"],"crossReferences":{"drugbank":["DB15456"]},"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0003144","EFO_0001645","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for heart failure and cardiovascular disease and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL419792","canonicalSmiles":"CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1","inchiKey":"RKZSNTNMEFVBDT-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMANIROLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-95666E","Pnu-95666","Sumanirole"],"crossReferences":{"Wikipedia":["Sumanirole"],"drugbank":["DB06477"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4285883","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)[C@@H](OC(C)=O)C[C@]5(O)[C@@H]4CC[C@@H]3C2)O[C@@H](C)[C@@H]1O","inchiKey":"JLPDBLFIVFSOCC-XYXFTTADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEANDRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anvirzel","NSC-692219","Oleandrin"],"crossReferences":{"drugbank":["DB12843"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297206","canonicalSmiles":"F[Ag].N.N","inchiKey":"FJKGRAZQBBWYLG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER DIAMMINE FLUORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300152","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diammine silver fluoride","Silver diamine fluoride","Silver diammine fluoride"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297255","canonicalSmiles":"COC(=O)C1(OC(=O)c2cncn2[C@H](C)c2ccccc2)CC1","inchiKey":"DRAFVCKNYNQOKR-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABP-700","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abp-700"],"crossReferences":{"drugbank":["DB15411"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297504","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/c1ccc(OCCN(C)C)cc1)CO2","inchiKey":"ZEZFKUBILQRZCK-MJSCXXSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELORANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beloranib","ZGN-433","ZGN-440","Zgn-433","Zgn-440"],"crossReferences":{"drugbank":["DB12671"]},"linkedTargets":{"rows":["ENSG00000111142"],"count":1},"linkedDiseases":{"rows":["Orphanet_739","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297587","canonicalSmiles":"Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)N(C)C)C1","inchiKey":"KMIOJWCYOHBUJS-HAKPAVFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOROLANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vorolanib"],"crossReferences":{"drugbank":["DB15247"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297620","canonicalSmiles":"NC(=O)OC[C@H](N)Cc1ccccc1","inchiKey":"UCTRAOBQFUDCSR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLRIAMFETOL","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ADX-N-05","JZP-110","Jzp-110","R-228060","SKL-N-05","Solriamfetol","YKP-10A"],"crossReferences":{"DailyMed":["solriamfetol%20hydrochloride"],"drugbank":["DB14754"]},"childChemblIds":["CHEMBL4297212"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL4297865","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1","inchiKey":"UOFYSRZSLXWIQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIVERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A610","AC-0010","AC0010","ACEA100610","Abivertinib","Ac0010","Avitinib","EX-ACEA0010"],"crossReferences":{"drugbank":["DB15327"]},"childChemblIds":["CHEMBL4297866"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000010671"],"count":2},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000096","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297964","drugType":"Protein","blackBoxWarning":false,"name":"ACT-1 PEPTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Act-1 peptide","Acti peptide","Granexin","Granexin peptide","Peptide 328967"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298110","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC MALTOL","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accrufer","Feraccru"],"synonyms":["Ferric maltol","Iron maltol","ST-10","ST10","ST10-021","St10-021"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for anemia (phenotype) and iron deficiency anemia."}
{"id":"CHEMBL4298127","drugType":"Unknown","blackBoxWarning":false,"name":"VRC-01LS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VRC-01LS","VRC01LS","Vrc-01ls","Vrc-hivmab080-00-ab","Vrc01ls"],"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","EFO_0000180"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298134","drugType":"Antibody","blackBoxWarning":false,"name":"OBEXELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obexelimab","XMAB-5871","XMAB5871","Xmab5871"],"linkedTargets":{"rows":["ENSG00000072694","ENSG00000177455"],"count":2},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL435883","canonicalSmiles":"CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)[O-])c3O[C@H]2C[C@H]1O.[Na+]","inchiKey":"YTCZZXIRLARSET-VJRSQJMHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BERAPROST SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1207745","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beraprost sodium","Beraprost sodium salt","MDL-201129","ML-1129","Procylin","TRK-100","TRK-100STP"],"crossReferences":{"PubChem":["144206467"],"drugbank":["DB05229"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL447183","canonicalSmiles":"N#Cc1ccc(C(=O)N2CCC3(CC2)N=C(N)c2c(F)ccc(F)c2N3)cn1","inchiKey":"GIZYIOOBBUHOBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-C102222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-C102222"],"crossReferences":{"drugbank":["DB07405"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45024","canonicalSmiles":"C[S+](C)CC[C@H](N)C(=O)O","inchiKey":"YDBYJHTYSHBBAU-YFKPBYRVSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIOSULFONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["17728"]},"childChemblIds":["CHEMBL1797128","CHEMBL540394"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL452231","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O","inchiKey":"NRUKOCRGYNPUPR-QBPJDGROSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENIPOSIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vumon"],"synonyms":["NSC-122819","Teniposide","VM-26","VM26"],"crossReferences":{"drugbank":["DB00444"]},"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000220","EFO_0000574","MONDO_0003541"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL452461","canonicalSmiles":"O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2","inchiKey":"BDABGOLMYNHHTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERZINFOTEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EAA-090","Perzinfotel"],"crossReferences":{"drugbank":["DB12365"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL452648","canonicalSmiles":"O=C(Nc1cc(Br)c(O)c(Br)c1)c1ccccc1","inchiKey":"HKODPZBPODONGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL452648","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459149","canonicalSmiles":"O=C([C@@H]1CCCN1C(=O)CCn1c(=O)c(-c2ccccc2)nc2ccccc21)N1CCCC1","inchiKey":"KWCKZIJGKMCYCI-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL459149","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594395","canonicalSmiles":"O=C([O-])CCCO.[K+]","inchiKey":"TXSIWDVUJVMMKM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxybate potassium","Potassium oxybate"],"crossReferences":{"DailyMed":["potassium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL4594580","drugType":"Unknown","blackBoxWarning":false,"name":"NJH-395","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NJH-395","NJH395","Njh-395","Njh395"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460460","canonicalSmiles":"N#Cc1cnn(-c2ccc(Cl)cc2)c1N","inchiKey":"WIWSALMJHPGFDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460460","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650225","canonicalSmiles":"CO[C@]1(CN2CCN3CCCC[C@@H]3C2)/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3","inchiKey":"BJTFTQIBRVBSBH-VCQPVEJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MURIZATOCLAX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 397","AMG-397","Murizatoclax"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650483","drugType":"Antibody","blackBoxWarning":false,"name":"ERFONRILIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erfonrilimab","KN-046","KN046","Kn046"],"linkedTargets":{"rows":["ENSG00000163599","ENSG00000120217"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000576","EFO_0005922","EFO_0005537","EFO_0002517","EFO_0000182","EFO_0000574","EFO_0003060"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL491","canonicalSmiles":"CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"YPQLFJODEKMJEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYFLUTAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-hydroxyflutamide","2-hydroxyflutamide","Hydroxy-flutamide","Hydroxyflutamide"],"crossReferences":{"PubChem":["144208402","144213961","17388977","174007324","56314870"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL500724","canonicalSmiles":"NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"ZVQZIVCQLFGXFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07256"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL510038","canonicalSmiles":"Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1","inchiKey":"NQQBNZBOOHHVQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL510038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL520613","canonicalSmiles":"Cc1c(CCO)sc[n+]1CCCCCCCCCCCC[n+]1csc(CCO)c1C.[Br-].[Br-]","inchiKey":"AFJCGBHHSKAACR-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBITIAZOLIUM BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1183040","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albitiazolium bromide","SAR-97276A","SAR97276A","Sar97276a"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL550795","canonicalSmiles":"O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1","inchiKey":"KSFDVNIKNYXUIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL550795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08191"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL562668","canonicalSmiles":"CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1","inchiKey":"UNAZAADNBYXMIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTENABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-945,598","CP-945598","CP-945598-01","Cp-945598","Otenabant","Otenabant hydrochloride"],"crossReferences":{"Wikipedia":["Otenabant"],"drugbank":["DB11745"]},"childChemblIds":["CHEMBL2103817","CHEMBL3526399"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL58","canonicalSmiles":"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21","inchiKey":"KKZJGLLVHKMTCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOXANTRONE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mitoxantrone HCl","Novantrone"],"synonyms":["Misostol","Mitoxantrone","NSC-279836","Novantrone"],"crossReferences":{"PubChem":["11111482","11111483","142727","162108252","50111146","85856281","90341083","92763439"],"Wikipedia":["Mitoxantrone"],"drugbank":["DB01204"],"chEBI":["50729"]},"childChemblIds":["CHEMBL1200827","CHEMBL1417019"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0011061","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_1001052","MONDO_0003541","EFO_0000565","EFO_0000178","EFO_0004251","EFO_0000339","MONDO_0019460","EFO_0004289","EFO_0000330","EFO_0000673","EFO_0000196","EFO_0000326","EFO_0000182","EFO_1001830","MONDO_0020743","EFO_0008522","EFO_0000198","EFO_0002618","EFO_0000616","EFO_0006859","EFO_0000220","MONDO_0019457","MONDO_0008170","EFO_0000403","EFO_0000222","EFO_0003929","EFO_1000286","EFO_1001968","EFO_0000224","MONDO_0008315","EFO_0003843","EFO_0001663","EFO_0000311","EFO_0000211","MONDO_0005301","MONDO_0001023","EFO_0000095","MONDO_0019472","EFO_0000574","EFO_0004256","MONDO_0018906","EFO_0001378"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 6 approved and 41 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL66380","canonicalSmiles":"O=C(O)CNC(=O)NC1CCCCC1","inchiKey":"NVORCMBCUHQRDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(3-Cyclohexylureido)Acetic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(3-Cyclohexylureido)Acetic Acid"],"crossReferences":{"drugbank":["DB08256"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66907","canonicalSmiles":"NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)c(F)c2F)cc1","inchiKey":"AANTYZRUJFNZFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66907","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6993","canonicalSmiles":"Nc1nc2ccccc2c(=O)[nH]1","inchiKey":"SDTFBAXSPXZDKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6993","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03780"],"chEBI":["85558"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL715","canonicalSmiles":"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1","inchiKey":"KVWDHTXUZHCGIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLANZAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arkolamyl","Olanzapine","Zalasta","Zyprexa","Zyprexa zydis"],"synonyms":["LY-170053","LY170053","Olansek","Olanzapine","Olanzapine apotex","Olanzapine cipla","Olanzapine glenmark","Olanzapine mylan","Olanzapine teva","Olazax","Olazax disperzi","Zyprexa velotab"],"crossReferences":{"DailyMed":["olanzapine","olanzapine%20pamoate"],"PubChem":["144205109","170465009","174006883","26719852","26750094","29215187","49666419"],"Wikipedia":["Olanzapine"],"drugbank":["DB00334"],"chEBI":["7735"]},"childChemblIds":["CHEMBL1201741","CHEMBL3989694"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004566","EFO_0004280","MONDO_0002009","HP_0000726","EFO_0003847","HP_0001824","EFO_0009267","HP_0002018","EFO_0004247","EFO_0000289","MONDO_0002050","HP_0002017","EFO_0003761","EFO_0009854","HP_0002013","HP_0012167","MONDO_0004976","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_0004215","EFO_0000616","EFO_0005203","EFO_0005088","EFO_0006911","HP_0012076","HP_0002039","EFO_0000677","EFO_1000904","EFO_0003758","EFO_0009963","EFO_0005407","EFO_0010702","HP_0002315","HP_0000713","EFO_0003852","Orphanet_399","Orphanet_79292","MONDO_0021148","EFO_0004888","EFO_0004699","EFO_0005411"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 8 approved and 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL729","canonicalSmiles":"Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O","inchiKey":"KJHKTHWMRKYKJE-SUGCFTRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOPINAVIR","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kaletra"],"synonyms":["A-157378-0","A-157378.0","ABT-378","Aluviran","Koletra","Lopinavir","Lopinavir, (s-(2s,4s,5s))-","Lopinavir-","Lopinavirum"],"crossReferences":{"DailyMed":["lopinavir"],"PubChem":["124893167","144205757","170464773","26757998","50111692"],"Wikipedia":["Lopinavir"],"drugbank":["DB01601"],"chEBI":["31781"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for hiv-1 infection and hiv infection and has 11 investigational indications."}
{"id":"CHEMBL81421","canonicalSmiles":"Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"IELOKBJPULMYRW-NJQVLOCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-ALPHA-TOCOPHERYL SUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Tocopheryl Succinate"],"crossReferences":{"PubChem":["144206109","144207766","50112815"],"drugbank":["DB14001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL90","canonicalSmiles":"NCCc1c[nH]cn1","inchiKey":"NTYJJOPFIAHURM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HISTAMINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".beta.-aminoethylglyoxaline","Ergamine","Ergotidine","Histamine","NSC-33792"],"crossReferences":{"PubChem":["104171171","11111275","124880328","144203717","170465001","26753351","26753352","8139979","90341171"],"Wikipedia":["Histamine"],"drugbank":["DB05381"],"chEBI":["18295"]},"childChemblIds":["CHEMBL1533310","CHEMBL544208","CHEMBL3989520","CHEMBL535166"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0005271","EFO_0000222","EFO_0005952","EFO_0000565","MONDO_0005277","MP_0001845","EFO_0005531","MONDO_0005301","EFO_0000678","EFO_0000389","EFO_0004616","MONDO_0004979","MONDO_0002367","MONDO_0003276","MONDO_0024880","EFO_0003956"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1939 and has 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL93268","canonicalSmiles":"O=N[O-].[Na+]","inchiKey":"LPXPTNMVRIOKMN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM NITRITE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1161681","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sodium nitrite"],"synonyms":["E250","INS NO.250","INS-250","NSC-77391","Natrii nitris","Natrum nitrosum","Nitrous acid soda","Nitrous acid, sodium salt","Sodium Nitrite","Sodium nitrite"],"crossReferences":{"DailyMed":["sodium%20nitrite"],"DrugCentral":["4797"],"PubChem":["144209353","144210345","17388728","17389803"],"Wikipedia":["Sodium_nitrite"],"chEBI":["78870"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for poisoning and has 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL950","canonicalSmiles":"O=C(O)C(=O)c1ccccc1","inchiKey":"FAQJJMHZNSSFSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOYL FORMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoyl formic acid"],"crossReferences":{"drugbank":["DB02279"],"chEBI":["18280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL996","canonicalSmiles":"CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21","inchiKey":"WZOZEZRFJCJXNZ-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFOXITIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cenomycin","Mefoxin","Mefoxitin"],"synonyms":["Cefoxitin","J01DC01","Mefoxin"],"crossReferences":{"DailyMed":["cefoxitin%20sodium"],"PubChem":["144206560","170465105"],"Wikipedia":["Cefoxitin"],"drugbank":["DB01331"],"chEBI":["209807"]},"childChemblIds":["CHEMBL1200530"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL9960","canonicalSmiles":"CC[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"MXNGYQJJYRVGGJ-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7624","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-7624","Azd 7624","Azd-7624"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MP_0001845","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
